Representing and supporting medical oncologists in the UK

The Association of Cancer Physicians

The ACP is recognised by the Royal College of Physicians and the Department of Health as the specialty association for medical oncologists. The executive committee is made up of democratically elected clinicians representing the views and concerns of the membership. Membership of the ACP gives medical oncologists an independent voice in the affairs of the Royal College of Physicians, the Joint Collegiate Council for Oncology (JCCO) and the Specialty Advisory Committee (SAC), who supervise training and accreditation.

Through this, we:

  • Promote the views and interests of medical oncologists to the DoH and RCP
  • Influence policy on consultant expansion
  • Assist in the development of training curricula and the specialty examination
  • Participate in NICE appraisals and guideline development
  • Encourage the development of best practice to benefit patients
  • Support members for National Clinical Impact Awards

If you are working as a medical oncologist, or a trainee, in the UK then we would encourage you to join. Details here.

Advances in Biotherapies Workshop

 

Latest News

Advances in Biotherapies Workshop

Posted on

Friday 14 October 2022 @ Hilton Leeds City Hotel, Leeds.

This workshop aims to highlight some of the new advances in the rapidly expanding field of biotherapies.  This includes immunotherapies and novel indications, cellular therapies and technologies and advances in liquid biopsies.  Presentations by leading experts will be facilitated with the case-based discussion and interactive panel discussions regarding developments and patients' cancer care.

Read More...

New regimen-specific consent forms from the UK Chemotherapy Board

Posted on

National regimen-specific consent forms - updated forms available.  Regimen-specific consent forms continue to be regularly reviewed and updated.  The most recently updated forms are for breast cancer, however all the forms are here.

The UK Chemotherapy Board has also recently issued new guidance on:

Read More...